<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Curcuma longa</italic> L. (Zingiberaceae) is known to contain two main classes of secondary metabolites, phenolic curcuminoids, and essential oils, including the major components α-turmerone and β-turmerone. Despite the essential oil from 
 <italic>Curcuma longa</italic> L. administered via intraperitoneal injection demonstrating a strong antiarthritic effect in female rats with SCW-induced arthritis, significant morbidity and mortality have been observed, which do not support the use of this EO against arthritis [
 <xref rid="B97-plants-09-01252" ref-type="bibr">97</xref>]. On the contrary, a good antiarthritic effect has been demonstrated in experimental rheumatoid arthritis for curcuminoid-containing turmeric extracts [
 <xref rid="B98-plants-09-01252" ref-type="bibr">98</xref>], and good antiarthritic potential has been observed for curcumin, the principal curcuminoid of turmeric. Nonose and coworkers demonstrated that this compound was able to reduce the inflammatory response in zymosan-induced arthritis [
 <xref rid="B99-plants-09-01252" ref-type="bibr">99</xref>].
</p>
